Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Streamline Health® Expands Agreement With Existing eValuator™ Client to Add RevID™
-
AppTech Successfully Boards its First International Airport Onto its Newly Acquired FinZeo Platform for Payment Processing
-
UPM finalized the sale of its Steyrermühl site to HEINZEL GROUP
-
DSM: Net Asset Value(s) and Portfolio
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
ProVen Growth and Income VCT plc: Total voting rights
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 29 12 2023] - (CGWL)
-
ProVen VCT plc: Total voting rights
-
Net Asset Value(s)
-
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID
-
Director/PDMR Shareholding
-
ExCellThera to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference and to Participate in Upcoming Investor Conferences
-
GRIID Common Stock Listed on Cboe Canada after Completion of Business Combination with Adit EdTech Acquisition Corp.
-
Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
-
XORTX Welcomes New Member to the Board of Directors
-
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies
-
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
ASLAN Pharmaceuticals Announces Participation in January Investor Conferences
-
Bitfarms Earns 446 BTC in December 2023 and 4,928 BTC for the Full Year 2023
-
5E Advanced Materials Commences Mining Operations at 5E Boron Americas Complex
-
Predictive Oncology to Participate in Upcoming San Francisco Conferences
-
Kymera Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024
-
Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
ICG Enterprise Trust Plc: Voting Rights and Capital
-
Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
ARMOUR Residential REIT, Inc. Confirms January 2024 Common Share and Series C Preferred Share Dividends
-
Nxu Finishes 2023 by Kicking Off Production of NxuOne™ EV Charging Solutions
-
Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Signing Day Sports Commences Collaboration as the Exclusive Recruiting Platform Provider for Elite Development Program (EDP Soccer)
-
Culligan Acquires Primo Water International Businesses Across Europe, Advances Mission to Increase Access to Clean, Sustainable, Better-Tasting Water
-
Flash News: OKX Wallet's DEX Now Supports BTC Cross-Chain Swaps
-
Flash News: OKX Wallet's DEX Now Supports BTC Cross-Chain Swaps
-
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
-
CAA North & East Ontario urges public awareness as new towing rules come into effect
-
NI 62-103 Report
-
U.S. Energy™ Acquires Two Refined Product Terminals in Illinois
-
The Ensign Group Acquires Skilled Nursing Facility in Nevada
-
The Ensign Group Acquires Skilled Nursing Facility in Tennessee
-
TechImmune to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Global Net Lease, Inc. Announces Common Stock Dividend for the First Quarter 2024
-
Newsweek Names USI Insurance Services One of America’s Greatest Workplaces for Diversity
-
Total Voting Rights and Capital
-
Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock
-
Transactions in connection with share buyback programme
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LXI REIT PLC
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LONDONMETRIC PROPERTY PLC
-
DSV, 1080 - SHARE BUYBACK IN DSV A/S
